Manganese therapy for dyslipidemia and plaque reversal in murine models

Dear Editor, Cardiovascular diseases(CVDs)and related metabolic disorders continue to rank as the leading cause of human mortality,caus-ing＞20 million deaths per year worldwide.Hyperlipidemia,or ele-vated circulating lipid levels,stands out as the primary risk factor of CVDs,notably through the inception of atherosclerosis[1].